A 55-year-old male patient, known since childhood as having type 2 von Willebrand disease (vWD), with very mild symptoms, with one or even less annualized bleeding rate (ABR), was treated on-demand with FVIII containing vWF. Here, VWF is linked to Von Willebrand disease type 2.